Most not too long ago, it's been discovered that conolidine and the above derivatives act to the atypical chemokine receptor 3 (ACKR3. Expressed in related areas as classical opioid receptors, it binds to some wide array of endogenous opioids. Unlike most opioid receptors, this receptor functions to be a scavenger and won't activate a 2nd messenger